98%
921
2 minutes
20
Background: Despite repeating proteinuria measurements multiple times during the clinical course of a patient with CKD, clinicians may overlook the significance of temporal patterns of proteinuria. In addition, it is unclear whether proteinuria trajectories identify sub-populations with varying risks of adverse clinical outcomes.
Methods: We used group-based trajectory modeling to identify proteinuria trajectories based on annual urine protein-to-creatinine ratio (UPCR) measurements in 3209 participants of the Chronic Renal Insufficiency Cohort Study who were alive and did not reach end-stage kidney disease (ESKD) within 3 years of study entry. Multivariable-adjusted Cox proportional hazards models tested the associations of UPCR trajectories with ESKD and death in those who survived beyond the 3rd annual visit.
Results: Trajectory analyses identified 4 discrete groups based on annual UPCR measurements: low-slowly rising (n=1528), high-slowly rising (n=1363), regressing (n=114), and rapidly rising (n=204). Compared to the low-slowly rising proteinuria trajectory group, participants in the other proteinuria trajectory groups had lower socioeconomic status, a greater prevalence of comorbid conditions, and lower eGFR. During a median follow-up of 8.6 years, 547 participants progressed to ESKD, and 836 participants died. Compared to the low-slowly rising group, all proteinuria trajectory groups were associated with higher risks of subsequent ESKD, but only the high-slowly rising group was associated with a higher risk of death.
Conclusions: Trajectories of repeated proteinuria measurements identify subgroups of patients with CKD that have increased risks of ESKD and death independent of known risk factors.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.34067/KID.0000000849 | DOI Listing |
J Diabetes Res
August 2025
Department of Endocrinology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
This longitudinal cohort study is aimed at examining the natural progression trajectories of diabetic kidney disease (DKD) in Type 2 diabetes mellitus (T2DM), assessing estimated glomerular filtration rate (eGFR) and albuminuria patterns over time. This longitudinal observational study analyzed 694 hospitalized patients with T2DM, featuring a cohort with a median age of 59.0 years (interquartile range [IQR] 52.
View Article and Find Full Text PDFNephrol Dial Transplant
August 2025
Division of Nephrology, University Health Network, Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
IgA nephropathy (IgAN) is the most common primary glomerulonephritis worldwide. The pathogenesis of IgAN is complex, characterized by gut mucosa-kidney interactions which lead to the production of galactose-deficient IgA1 and formation of immune complexes with anti-glycan antibodies. Both arms of the adaptive and innate immune system are implicated in modifying or amplifying inflammatory cascades which lead to disease progression.
View Article and Find Full Text PDFKidney360
June 2025
Division of Nephrology, Department of Medicine, University of Illinois Chicago, Chicago, IL 60612, USA.
Background: Despite repeating proteinuria measurements multiple times during the clinical course of a patient with CKD, clinicians may overlook the significance of temporal patterns of proteinuria. In addition, it is unclear whether proteinuria trajectories identify sub-populations with varying risks of adverse clinical outcomes.
Methods: We used group-based trajectory modeling to identify proteinuria trajectories based on annual urine protein-to-creatinine ratio (UPCR) measurements in 3209 participants of the Chronic Renal Insufficiency Cohort Study who were alive and did not reach end-stage kidney disease (ESKD) within 3 years of study entry.
Clin J Am Soc Nephrol
June 2025
Department of Internal Medicine; The Institute of Kidney Diseases, Yonsei University College of Medicine, Seoul, South Korea.
Kidney Int Rep
May 2025
Pediatric Nephrology Division, Department of Pediatrics I, University of Heidelberg, Heidelberg, Germany.
Introduction: There are discrepant findings regarding the effect of dyslipidemia on disease progression in adult patients with chronic kidney disease (CKD).
Methods: In a prospective cohort study of children with stage 3 to 5 (predialysis) CKD, triglycerides (TGs), total cholesterol (CHOL), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) were measured semiannually. We investigated whether CKD progression is associated with serum lipid levels at baseline and with lipid trajectories during follow-up.